Deal secured for cancer drug
PHARMACEUTICAL company ProStrakan has secured a deal to sell its drug for cancer pain across Germany.
The Galashiels-based firm has announced that Abstral will be launched in the country at the beginning of next year.
The drug – formerly branded as Rapinyl – is a fast-dissolving tablet which is placed under a patient's tongue to manage breakthrough cancer pain.
Chief executive Dr Wilson Totten said: "Our German operation is well advanced in its preparations for launch and we look forward to introducing German oncologists to this important product for cancer patients."
ProStrakan has just received marketing authorisation from the German regulatory authority BfArM for Abstral.
- Rangers run into the ground as furious HMRC battles to claw back tax
- Broken Rangers: Club signals intention to go into administration
- Rangers: ‘Crisis will soon be over and Rangers FC will survive’
- Scottish independence: David Cameron set to snub Alex Salmond’s separation talks bid
- Scottish independence: David Cameron offers a deal to reject independence
- Scottish independence: David Cameron offers a deal to reject independence
- Devo-max merely a dodgy back-up plan to save SNP, says Jim Sillars
- Scottish independence: No breakthrough in talks between Alex Salmond and Michael Moore
- The Rumour Mill: Thursday’s football news and gossip
- Scottish independence: David Cameron set to snub Alex Salmond’s separation talks bid
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Friday 17 February 2012
Today
Light rain
Temperature: 5 C to 9 C
Wind Speed: 24 mph
Wind direction: South west
Tomorrow
Cloudy
Temperature: -1 C to 6 C
Wind Speed: 25 mph
Wind direction: West

